Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/16/2007WO2007092403A1 N-phenylbenzotriazolyl c-kit inhibitors
08/16/2007WO2007092400A1 Aminophenyl derivatives as selective androgen receptor modulators
08/16/2007WO2007092391A1 Androgen receptor modulators and methods of treating disease using the same
08/16/2007WO2007092334A1 Method of treating sleep disorders
08/16/2007WO2007092333A1 Use of olopatadine for treating sleep disorders
08/16/2007WO2007092284A2 Low dose no donor-containing transdermal patch
08/16/2007WO2007092213A2 Inhibitors of e1 activating enzyme
08/16/2007WO2007092207A1 Compositions for the delivery of substituted naphthyl indole derivatives and methods of their use
08/16/2007WO2007092190A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
08/16/2007WO2007092178A1 Hydrate forms of amg706
08/16/2007WO2007092161A2 A direct cellular energy delivery system
08/16/2007WO2007092157A1 7-(1h-imidazol-4-yl) methyl) -5,6,7,8-tetrahydroquinoline
08/16/2007WO2007092088A1 Compositions comprising amphotericin b
08/16/2007WO2007092086A2 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
08/16/2007WO2007092031A1 Stable pharmaceutical formulations of montelukast sodium
08/16/2007WO2007092026A1 Dipyridamole extended-release formulations and process for preparing same
08/16/2007WO2007092000A1 Inhibitors of hcv replication
08/16/2007WO2007091970A1 Novel method and compositions for treatment of tinnitus
08/16/2007WO2007091950A1 Benzimidazoles and imidazopyridines useful in the treatment of diseases or disorders associated with cannabinoid receptor 2 (cb2) such as pain
08/16/2007WO2007091948A2 Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1
08/16/2007WO2007091947A2 Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1
08/16/2007WO2007091946A1 Use of spiro [ imidazolidine-4, 3'-indole] 2, 2', 5' (1h) triones for treatment of conditions associated with vanilloid receptor 1
08/16/2007WO2007091857A1 Use of a pyrimidinedione derivative for preventing or treating hepatitis c
08/16/2007WO2007091736A1 Novel coumarin derivative having antitumor activity
08/16/2007WO2007091719A1 Concomitant anti-gpvi antibody therapy and novel medicinal use thereof
08/16/2007WO2007091707A1 Pharmaceutical composition for preventing and/or treating bone disease, functional food, health food, pharmaceutical preparation and tooth root-periodontal tissue formation promoting agent containing the composition
08/16/2007WO2007091703A1 N-hydroxyacrylamide compounds
08/16/2007WO2007091694A1 Whitening dermatological preparations
08/16/2007WO2007091678A1 Rheumatoid arthritis-preventive agent for oral intake
08/16/2007WO2007091644A1 Fungal growth inhibitor
08/16/2007WO2007091623A1 Pharmaceutical composition comprising meglitinide for prevention of hepatic fibrosis
08/16/2007WO2007091622A1 Anti-cancer pharmaceutical composition
08/16/2007WO2007091613A1 Prophylactic or therapeutic agent for alzheimer's disease, and food/beverage
08/16/2007WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate
08/16/2007WO2007091557A1 Pharmaceutical composition for treatment or prevention of liver cancer
08/16/2007WO2007091501A1 Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease
08/16/2007WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same
08/16/2007WO2007091393A1 10a-AZALIDE COMPOUND
08/16/2007WO2007091350A1 Solid-phase membrane containing surface-modified albumin or surface-modified serum albumin-metal porphyrin complex and use thereof
08/16/2007WO2007091328A1 Method for treatment of lung cancer
08/16/2007WO2007091313A1 Cytokine production inhibitor and heterocyclic phenoxy derivative
08/16/2007WO2007091279A1 Formulations of clopidogrel bisulphate
08/16/2007WO2007091241A1 Treatment of ovarian cancer
08/16/2007WO2007091176A1 Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives
08/16/2007WO2007091165A1 A pharmaceutical composition comprising oenothein c useful for the treatment of peptic ulcer diseases
08/16/2007WO2007091147A1 Oxazolidinones containing oxindoles as antibacterial agents
08/16/2007WO2007091140A1 Substituted phenylsulfamoyl compounds as ppar agonists
08/16/2007WO2007091109A1 Pharmaceutical composition comprising tacrolimus
08/16/2007WO2007091107A1 Treatment of duchenne muscular dystrophy
08/16/2007WO2007091106A2 Treatment of duchenne muscular dystrophy
08/16/2007WO2007091059A1 Preparation and composition of a solid dosage form containing tacrolimus and/or sirolimus
08/16/2007WO2007091046A1 Chemical compounds
08/16/2007WO2007091037A2 Metal-containing virucidal compositions and uses
08/16/2007WO2007091018A1 Non-natural amino acid derivatives
08/16/2007WO2007090949A1 Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
08/16/2007WO2007090923A1 Process for manufacturing entacapone
08/16/2007WO2007090912A1 IN VITRO USE OF NF-kB INHIBITORS TO INDUCE THE SELECTIVE DEPLETION OF ALLOREACTIVE T-LYMPHOCYTES, DERIVATIVE PHARMACEUTICAL COMPOSITIONS AND USES OF SAME
08/16/2007WO2007090897A1 Loading of hydrophobic drugs into hydrophilic polymer delivery systems
08/16/2007WO2007090894A1 Oligosaccharide mixture
08/16/2007WO2007090888A1 3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists
08/16/2007WO2007090887A1 3, 9-diazabicyclo [3.3. 1]nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors
08/16/2007WO2007090886A1 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/16/2007WO2007090883A1 Extended release formulation
08/16/2007WO2007090882A2 Pharmaceutical extended release compositions comprising pramipexole
08/16/2007WO2007090859A1 Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{ [ (r)-2-hydroxy-2- (8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl) eth ylaminoimethyl] } -5-methoxyphenylcarbamoyl) ethyl] piperidin-4-yl ester and its use for the treatment of pulmonary disorders
08/16/2007WO2007090854A1 Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders
08/16/2007WO2007090853A1 Enantiomers of amino pyrimidine compounds for the treatment of inflammatory disorders
08/16/2007WO2007090852A1 Amino pyrimidine compounds for the treatment of inflammatory disorders
08/16/2007WO2007090844A1 Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation
08/16/2007WO2007090841A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
08/16/2007WO2007090840A1 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia
08/16/2007WO2007090826A1 Piperidine derivatives as cxcr3 receptor antagonists
08/16/2007WO2007090794A1 Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic
08/16/2007WO2007090793A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
08/16/2007WO2007090752A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
08/16/2007WO2007090751A1 Heterobicyclic amide derivatives
08/16/2007WO2007090750A1 Trialkylsilylbenzylaminocarboxyindoles, indazoles and indolines and their use in treating cetp-mediated disorders
08/16/2007WO2007090748A1 Benzamide and heteroarene derivatives
08/16/2007WO2007090733A1 Nitrooxy derivatives suitable as alpha2 adrenergic receptor agonists
08/16/2007WO2007090720A2 Use of 2-imidazoles for the treatment of cns disorders
08/16/2007WO2007090661A2 Active substance combination comprising azolylcarbinol compounds
08/16/2007WO2007090646A1 Nebulised antibiotics for inhalation therapy
08/16/2007WO2007090617A2 Thiadiazole derivatives for the treatment of neuro degenerative diseases
08/16/2007WO2007090595A1 Solid formulations of valacyclovir hydrochloride
08/16/2007WO2007090574A1 Protease inhibitor for wound treatment
08/16/2007WO2007090494A1 Amino indazole derivatives
08/16/2007WO2007090493A1 Indazole heteroaryl derivatives
08/16/2007WO2007090409A1 Use of kcnq-openers for threating or reducing the symptoms of schizophrenia
08/16/2007WO2007090289A1 Combinations of botanical extracts for promoting cardiovascular health
08/16/2007WO2007090255A2 Polymeric implant and a process for obtaining a polymeric implant
08/16/2007WO2007076467A3 Use of anecortave acetate as an adjunct during filtration bleb surgery
08/16/2007WO2007076460A3 Substituted thiazole ureas useful as inhibitors of protein kinases
08/16/2007WO2007076444A3 Improved oral compositions comprising zinc citrate and/or tocopherol agents
08/16/2007WO2007076086A3 Tricyclic spiro compounds useful as transforming growth factor modulators
08/16/2007WO2007075838A3 Pure and stable tiotropium bromide
08/16/2007WO2007075834A3 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of epilepsy
08/16/2007WO2007075825A3 Lipophilic anticancer drug compounds
08/16/2007WO2007075794A3 Oral formulations comprising tigecycline
08/16/2007WO2007075702A3 Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and h3 receptor antagonist/inverse agonist
08/16/2007WO2007075698A3 Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
1 ... 3621 3622 3623 3624 3625 3626 3627 3628 3629 3630 3631 3632 3633 3634 3635 3636 3637 3638 3639 3640 3641 ... 7860